Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Myelofibrosis

Clinical Trial at: Texas Oncology - Plano

INCB 39110-209, An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

  • Details

ClinicalTrials.gov ID: NCT03144687
Diagnosis Type: NA
USOR Number: 17085

  • Practice Details

3705 West 15th Street
Plano, Texas 75075
287.21 mi. away
P: (972) 867-3577

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Plano

TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency - CO-338-052

  • Details

ClinicalTrials.gov ID: NCT02952534
Diagnosis Type: NA
USOR Number: 16237

  • Practice Details

3705 West 15th Street
Plano, Texas 75075
287.21 mi. away
P: (972) 867-3577

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Plano

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

3705 West 15th Street
Plano, Texas 75075
287.21 mi. away
P: (972) 867-3577

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Plano

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: NA
USOR Number: 19054

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Plano

(42756493BLC3001) A Phase 3 Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations (THOR)

  • Details

ClinicalTrials.gov ID: NCT03390504
Diagnosis Type: NA
USOR Number: 17133

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Texas Oncology - Plano

A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PROOF Trial (QBGJ398-301)

  • Details

ClinicalTrials.gov ID: NCT03773302
Diagnosis Type: NA
USOR Number: 18264

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - Plano

(INCB 54828-207) A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

  • Details

ClinicalTrials.gov ID: NCT03822117
Diagnosis Type: NA
USOR Number: 19079

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Plano

(C3441020) A PHASE 2, NON-RANDOMIZED, OPEN LABEL, SINGLE ARM, MULTI-CENTER STUDY OF TALAZOPARIB FOR NEOADJUVANT TREATMENT OF GERMLINE BRCA1/2 MUTATION PATIENTS WITH EARLY TRIPLE-NEGATIVE BREAST CANCER

  • Details

ClinicalTrials.gov ID: NCT03499353
Diagnosis Type: NA
USOR Number: 18042

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Plano

A Randomized, Double-Blind, Phase 3 Study of Pemetrexed + Platinum Chemotherapy with or without Pembrolizumab (MK-3475) in TKI-resistant EGFR-mutated Tumors in Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Participants (KEYNOTE-789; MK-3475-789)

  • Details

ClinicalTrials.gov ID: NCT03515837
Diagnosis Type: NA
USOR Number: 19020

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - Plano

A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Plano

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: NA
USOR Number: 17079

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Plano

A Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Bacillus Calmette- Guerin (BCG) in Participants with High-risk Non-muscle Invasive Bladder Cancer (HR NMIBC) that is Persistent or Recurrent Following BCG Induction (KEYNOTE-676)

  • Details

ClinicalTrials.gov ID: NCT03711032
Diagnosis Type: High Risk
USOR Number: 17213

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Plano

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG™) Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Plano

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Texas Oncology - Plano

INCB 39110-209, An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

  • Details

ClinicalTrials.gov ID: NCT03144687
Diagnosis Type: NA
USOR Number: 17085

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Plano

TRITON2: A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency - CO-338-052

  • Details

ClinicalTrials.gov ID: NCT02952534
Diagnosis Type: NA
USOR Number: 16237

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Plano

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Carrollton

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: NA
USOR Number: 19054

  • Practice Details

4352 N Josey Lane
Carrollton, Texas 75010
288.14 mi. away
P: (972) 394-4368

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Carrollton

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

4352 N Josey Lane
Carrollton, Texas 75010
288.14 mi. away
P: (972) 394-4368

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Carrollton

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

4352 N Josey Lane
Carrollton, Texas 75010
288.14 mi. away
P: (972) 394-4368

More Details View Practice Page

Pages